UK markets closed
  • FTSE 100

    7,389.98
    +87.24 (+1.19%)
     
  • FTSE 250

    19,835.95
    +146.93 (+0.75%)
     
  • AIM

    956.64
    +9.47 (+1.00%)
     
  • GBP/EUR

    1.1822
    +0.0040 (+0.34%)
     
  • GBP/USD

    1.2495
    +0.0020 (+0.16%)
     
  • BTC-GBP

    24,203.86
    +640.89 (+2.72%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • S&P 500

    3,901.36
    +0.57 (+0.01%)
     
  • DOW

    31,261.90
    +8.77 (+0.03%)
     
  • CRUDE OIL

    110.35
    +0.46 (+0.42%)
     
  • GOLD FUTURES

    1,845.10
    +3.90 (+0.21%)
     
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • HANG SENG

    20,717.24
    +596.56 (+2.96%)
     
  • DAX

    13,981.91
    +99.61 (+0.72%)
     
  • CAC 40

    6,285.24
    +12.53 (+0.20%)
     

Global Clinical Laboratory Services Market to Reach $303.1 Billion by 2026

·27-min read
ReportLinker
ReportLinker

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. -Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, April 29, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Clinical Laboratory Services Industry" - https://www.reportlinker.com/p04707129/?utm_source=GNW
-Online interactive peer-to-peer collaborative bespoke updates
-Access to our digital archives and MarketGlass Research Platform
-Complimentary updates for one year

Global Clinical Laboratory Services Market to Reach $303.1 Billion by 2026

As Covid-19 financially disrupted healthcare organizations around the world, clinical laboratories of all sizes played a vital role in response to the pandemic by ramping up capacity to meet the increased demand for Covid-19 testing. The Covid-19 outbreak placed unprecedented demands on healthcare system in various countries with challenges of supply chain disruptions and heightened demand on health facilities. The accelerated pace at which the novel coronavirus spread around the world saturated hospital capacity and exposed the deficiencies in the public health system. The pandemic highlighted the critical role of diagnostic testing in outbreak control. As governments and health authorities around the world sought ways to increase access to reliable testing to screen for the disease, the amplified global demand for Covid-19 test kits led to shortages of laboratory-based molecular testing. Given the urgent global need for rapid, point-of-care diagnostic tests to deal with the continuous spread of the Covid-19 pandemic, rapid testing emerged as a vital tool to meet the unprecedented demand.

Amid the COVID-19 crisis, the global market for Clinical Laboratory Services estimated at US$222.7 Billion in the year 2020, is projected to reach a revised size of US$303.1 Billion by 2026, growing at a CAGR of 5.1% over the analysis period. Clinical Chemistry, one of the segments analyzed in the report, is projected to grow at a 4.8% CAGR to reach US$138 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Human & Tumor Genetics segment is readjusted to a revised 4.7% CAGR for the next 7-year period. This segment currently accounts for a 21.6% share of the global Clinical Laboratory Services market.

The U.S. Market is Estimated at $112.1 Billion in 2021, While China is Forecast to Reach $11.7 Billion by 2026

The Clinical Laboratory Services market in the U.S. is estimated at US$112.1 Billion in the year 2021. The country currently accounts for a 47.38% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$11.7 Billion in the year 2026 trailing a CAGR of 7.3% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR while Rest of European market (as defined in the study) will reach US$12.5 Billion by the close of the analysis period.

The market will continue to experience significant growth worldwide due to recent developments in diagnostic techniques, growth in the geriatric population and due to the growth of chronic diseases. The need to reduce hospital readmission rates and reducing hospitalization time has increased in the recent years, leading to increased compliance for diagnostic services among healthcare providers. Increasing patient awareness of disease diagnosis, climate change, growing prosperity of emerging markets, evolution to pathogens, advanced in the area of biotechnology in proteomics and genomics, and advances in interoperability and automation are driving the market for clinical laboratory services. Technological advancements are also driving market growth. Novel test areas such as genetic tests, companion diagnostics and molecular testing are witnessing significant growth and generating sizable revenues and margins for labs providing them. Advancements in molecular biology and genomics are yielding more advanced and accurate tests for various indications leading to their adoption.

Medical Microbiology & Cytology Segment to Reach $66.2 Billion by 2026

In the global Medical Microbiology & Cytology segment, USA, Canada, Japan, China and Europe will drive the 7.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$38.9 Billion in the year 2020 will reach a projected size of US$62.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2026, while Latin America will expand at a 8% CAGR through the analysis period.
Select Competitors (Total 125 Featured) -

  • ADICON Clinical Laboratories, Inc.

  • ARUP Laboratories

  • Bio-Reference Laboratories, Inc.

  • DaVita, Inc.

  • Enzo Clinical Labs

  • Genova Diagnostics, Inc.

  • Kingmed Diagnostics

  • Laboratory Corporation of America Holdings

  • Dynacare

  • Mayo Clinic Laboratories

  • NeoGenomics Laboratories

  • Genoptix, Inc.

  • Quest Diagnostics, Inc.

  • Sonic Healthcare Limited

  • Bioscientia Institut für Medizinische Diagnostik GmbH

  • American Esoteric Laboratories

  • SYNLAB International GmbH

  • The National Health Laboratory Service

  • Thyrocare Technologies Limited

  • Unilabs SA




Read the full report: https://www.reportlinker.com/p04707129/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of COVID-19 Pandemic and Looming Global Recession
Clinical Laboratories Step Up Strategies for Protecting Personnel
Assays for COVID-19 Detection
Clinical Labs Benefit from the Surge in COVID-19 Testing Volumes
Total Number of COVID-19 Tests Conducted in the Most Impacted
Countries: As of December 8th, 2020
COVID-19 Affects Fortunes of Non-COVID Diagnostics
Cancer Testing Dives During First Half of 2020
Labs Embark New Journeys to Retain Overall Volumes
At Home Testing Presents Challenges for Clinical Lab Services
An Introduction to Clinical Laboratory Services
Types of Tests Conducted in Medical Labs
Types of Clinical Laboratories
Global Market Prospects & Outlook
Hospital-based Laboratories Lead the Global Market
Developed Regions Lead, Developing Economies Present
Considerable Growth Opportunities
Competition
Consolidation Activity Gathers Pace
Select M&A Transactions in Clinical Laboratory Services
Industry (2019 & 2020)
World Brands
Recent Market Activity
Clinical Laboratory Services - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Healthcare Needs of Aging Population to Boost Demand for
Laboratory Services
Global Aging Population Statistics for the 65+ Age Group in
Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
Elderly Population (65+ Years) as a % of Total Population by
Developed, Less Developed and Least Developed Regions: 2019 &
2030
Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-
2025) & (2045-2050)
Increasing Incidence of Chronic Diseases Drives the World
Clinical Laboratory Services Market
Global Cancer Incidence: Number of New Cancer Cases in Million
for the Years 2018, 2020, 2025, 2030, 2035 and 2040
World Diabetes and Population Statistics (2019, 2030 & 2045)
Global HIV Prevalence: Number of People Living with AIDs
(in Thousands) by Region for 2018
Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015,
2020, 2025 and 2030
Rise in Healthcare Expenditure to Drive Growth
World Healthcare Expenditure (In US$ Billion) for the Years
2017-2023
Elderly Healthcare Expenditure as a % of GDP
With COVID-19 Highlighting the Threat Posed by Infectious
Diseases, Role of Clinical Labs in Testing Infectious Diseases
Grows in Importance
Infectious Diseases Remain Major Cause of Death in Under
Developed Regions: Breakdown of Leading Causes of Death in
Sub-Saharan Africa (in %)
Infectious Diseases Related Mortality High Among Children Below
5 Years: Breakdown of Leading Causes of Death in Children
Below 5 Years (in %)
Increasing Prevalence of Respiratory Infections Drive Growth
Global Number of Deaths Caused Due to Communicable Diseases (In
000s)
Lab Automation Speeds Up
Rise of Laboratory 4.0 Transforms Clinical Laboratory Space
Laboratory Information Systems Gain Traction amidst Growing
Need to Enhance Workflow Efficiencies and Reduce Costs
Artificial Intelligence: The Future of LIMS
Digitalization, Automation and AI Trends Shape Growth
Microbiology Laboratories Switch to Automation to Push Yields
World Laboratory Automation Market in US$ Billion for Years
2018, 2020, 2022, 2024 & 2026
Artificial Intelligence Holds Positive Implications for
Automation of Clinical Microbiology
Clinical Microbiology Market Benefits from Digitalization and
Robotization Trend
Integration of Clinical Microbiology with Cloud Computing
Advent of New & Advanced Devices Fuels Growth in Clinical
Laboratory Services Market
New Technologies and Tests Drive Demand for Specific Testing
Increasing Role of Advanced Tests in Clinical Treatment
Decision Making
Innovations Hold Potential to Improve Clinical Chemistry Lab
Performance
Disruptive Innovations in Clinical Lab Space Present Growth
Opportunities
Increasing Opportunities in Personalized Medicine and Clinical
Trial Services
Global Personalized Medicine Market: Revenues in US$ Million
for the Years 2019, 2021, 2023 and 2025
Autoimmune Disease Testing: Labs Seek Cost-Effective & High
Productivity Options
Genetic Disease Testing Offers Bright Prospects for Lab Services
Reduced Hospitalization Enhances Significance of Medical Labs
Standardization Gains Precedence in the Hunt for Automation
Assessing the Impact of Point-of-Care Testing on Clinical Labs
Hospital Laboratories to Transform into Profit Centers
Hospital Outreach Laboratories Deliver Better Value to Larger
Organizations
Physician Office Laboratories: Focus on Reducing Turnaround
Times for Testing
Emerging Clinical Laboratory Designs Focus on Improving Space
Utilization and Promote Healthy Work Environments
Laboratory Outsourcing Trend Gains Strength
Challenges Facing Lab Testing Market

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Clinical Laboratory Services
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Clinical Laboratory
Services by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Clinical Chemistry by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Clinical Chemistry by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Clinical Chemistry by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for Human &
Tumor Genetics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Human & Tumor Genetics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Human & Tumor Genetics
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Medical Microbiology & Cytology by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Medical Microbiology &
Cytology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Medical Microbiology &
Cytology by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 13: World Recent Past, Current & Future Analysis for
Other Test Types by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Other Test Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Other Test Types by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Hospital-based Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Revenues in
US$ Million for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Hospital-based Laboratories
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Hospital-based
Laboratories by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Independent Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Revenues in
US$ Million for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Independent Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Independent
Laboratories by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Physician Office-based Laboratories by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Physician Office-based
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Physician Office-based
Laboratories by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Clinical Laboratory Services Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2022
(E)
United States: A Major Market for Clinical Laboratory Services
A Glance at Major Growth Drivers
COVID-19 Accelerates Market Expansion
US-based Labs Ramp Up Operations Amidst the COVID-19 Situation
FDA Plays Instrumental Role in Influx of New Tests
CMS Prioritizes COVID-19 Testing: Announces New Reimbursement
Rules
Unmet Diagnostic Needs of Aging Population: Major Driver
US Elderly Population: Expected Growth Rates Over the Years
2005-2025
Increasing Burden of Chronic Diseases Drives Focus onto Early
Detection & Prevention
Cancer Statistics in the US
Leading Sites of New Cancer Cases in Males: 2020
Leading Sites of New Cancer Cases in Females: 2020
Prevalence of Diabetes in the US
Diabetes and Population Statistics in North America and
Caribbean Region (2019, 2030 & 2045)
Opportunities in Personalized Medicine and Clinical Trial Services
Growing Focus on Early Diagnosis
Impact of Scientific Advances & Role of Healthcare IT Solutions
Need to Reduce Healthcare Costs
Opportunities from Individual Testing & Population Screening
Initiatives
Clinical Laboratory Services: Systemic Challenges
Changing Healthcare Industry Dynamics Affect Clinical Lab
Testing Market
Healthcare Spending as a % of GDP in the US: 2010-2020
Key Trends & Issues
Anatomic Pathology & Cytology Testing: Personalized Medicine
Presents Positive Future
Esoteric Testing Market: Faster Growth than Routine Testing
Segment
Molecular Diagnostics: Promising Growth Opportunities
Drugs of Abuse Testing: Prospects Linked to Employment Levels
Future Holds Promise for Specialty Testing Market
Smaller Labs Embrace Digital Pathology Systems
Impact of Healthcare Spending Cuts on Routine & Specialty Lab
Tests
Increasing Role of Advanced Tests in Clinical Treatment
Decision Making
Toxicology Laboratories Market: An Insight
Genetic and Genomic Clinical Lab Testing Market: Promising
Prospects
Shift towards Managed Care - A Challenge for Independent
Clinical Labs?
ACO Business Model: A Challenge for Independent Labs
Integration of Clinical Care: Impact on Clinical Labs &
Anatomic Pathology Groups
Hospital Laboratory Outreach Programs: On the Rise
Physician Practices: The New Acquisition Targets
% of Independent Physicians in the US (2000, 2005 & 2018)
Cost Cutting Measures to Hit Lab Outreach Testing Business?
Shortened Hospital Stay Enhances Significance of Medical Labs
POCT Segment Withstands Cost Pressures
Quality Concerns Bring IT Solutions & Automation to the Fore
Move towards IQCP
Reimbursement Policies Strongly Influence Clinical Lab Services
Market
Challenges Facing Clinical Labs Market
Competitive Landscape
Providers of Clinical Laboratory Service in the US: A Review
Hospital-Based Labs
Registered Hospitals in the US by Type: 2018
Independent Labs
Independent Labs Market in the US (2019): Percentage Share
Breakdown of Revenues for Quest Diagnostics, LabCorp, Small
Independent Labs and Others
Physician Office-Based Labs and Others
Consolidation Activity Gathers Pace in Clinical Laboratory
Testing Market
Accreditation and Regulatory Scenario in the US
Clinical Laboratory Improvement Amendments (CLIA)
CLIA Laboratories Registered: March 2020
A2LA
ASCLS
CAP
An Overview of Select Regulations
Protecting Access to Medicare Act (PAMA) of 2014
Health Insurance Portability and Accountability Act of 1996
Substance Abuse and Mental Health Services Administration:
(SAMHSA) Regulation
Medicare Coverage for Screening Tests
Medicare Spending in the US by Category (2019): Percentage
Share Breakdown of Spending for Medicare Advantage, Inpatient
Hospital, Prescription Drugs, Physician Fee Schedule,
Outpatient Hospital and Others
Medicaid
Table 25: USA Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Test Type - Clinical Chemistry,
Human & Tumor Genetics, Medical Microbiology & Cytology and
Other Test Types - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Clinical Laboratory Services
by Test Type - Clinical Chemistry, Human & Tumor Genetics,
Medical Microbiology & Cytology and Other Test Types Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Clinical Laboratory
Services by Test Type - Percentage Breakdown of Value Revenues
for Clinical Chemistry, Human & Tumor Genetics, Medical
Microbiology & Cytology and Other Test Types for the Years
2012, 2021 & 2027

Table 28: USA Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Service Provider -
Hospital-based Laboratories, Independent Laboratories and
Physician Office-based Laboratories - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR

Table 29: USA Historic Review for Clinical Laboratory Services
by Service Provider - Hospital-based Laboratories, Independent
Laboratories and Physician Office-based Laboratories Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Clinical Laboratory
Services by Service Provider - Percentage Breakdown of Value
Revenues for Hospital-based Laboratories, Independent
Laboratories and Physician Office-based Laboratories for the
Years 2012, 2021 & 2027

CANADA
COVID-19 Widens the Business Case for Clinical Laboratory Services
Table 31: Canada Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Test Type - Clinical Chemistry,
Human & Tumor Genetics, Medical Microbiology & Cytology and
Other Test Types - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for Clinical Laboratory
Services by Test Type - Clinical Chemistry, Human & Tumor
Genetics, Medical Microbiology & Cytology and Other Test Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Clinical Laboratory
Services by Test Type - Percentage Breakdown of Value Revenues
for Clinical Chemistry, Human & Tumor Genetics, Medical
Microbiology & Cytology and Other Test Types for the Years
2012, 2021 & 2027

Table 34: Canada Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Service Provider -
Hospital-based Laboratories, Independent Laboratories and
Physician Office-based Laboratories - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR

Table 35: Canada Historic Review for Clinical Laboratory
Services by Service Provider - Hospital-based Laboratories,
Independent Laboratories and Physician Office-based
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Clinical Laboratory
Services by Service Provider - Percentage Breakdown of Value
Revenues for Hospital-based Laboratories, Independent
Laboratories and Physician Office-based Laboratories for the
Years 2012, 2021 & 2027

JAPAN
Clinical Laboratory Services Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2022 (E)
COVID-19 Testing Elevates Market Prospects
Table 37: Japan Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Test Type - Clinical Chemistry,
Human & Tumor Genetics, Medical Microbiology & Cytology and
Other Test Types - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 38: Japan Historic Review for Clinical Laboratory
Services by Test Type - Clinical Chemistry, Human & Tumor
Genetics, Medical Microbiology & Cytology and Other Test Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2012 through 2019 and % CAGR

Table 39: Japan 15-Year Perspective for Clinical Laboratory
Services by Test Type - Percentage Breakdown of Value Revenues
for Clinical Chemistry, Human & Tumor Genetics, Medical
Microbiology & Cytology and Other Test Types for the Years
2012, 2021 & 2027

Table 40: Japan Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Service Provider -
Hospital-based Laboratories, Independent Laboratories and
Physician Office-based Laboratories - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR

Table 41: Japan Historic Review for Clinical Laboratory
Services by Service Provider - Hospital-based Laboratories,
Independent Laboratories and Physician Office-based
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Clinical Laboratory
Services by Service Provider - Percentage Breakdown of Value
Revenues for Hospital-based Laboratories, Independent
Laboratories and Physician Office-based Laboratories for the
Years 2012, 2021 & 2027

CHINA
Clinical Laboratory Services Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2022 (E)
Clinical Laboratory Services Market in China: An Overview
COVID-19 Outbreak Spurs Huge Demand
Healthcare Reforms Bolster Opportunities
Independent Clinical Labs Gain from Prevailing Trends
Leading Independent Medical Labs in China (2019): Percentage
Breakdown of Revenues for Leading Players
Market Leaders Look to Expand Beyond Clinical Services
CNAL: The National Accreditation Body in China
Table 43: China Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Test Type - Clinical Chemistry,
Human & Tumor Genetics, Medical Microbiology & Cytology and
Other Test Types - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 44: China Historic Review for Clinical Laboratory
Services by Test Type - Clinical Chemistry, Human & Tumor
Genetics, Medical Microbiology & Cytology and Other Test Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2012 through 2019 and % CAGR

Table 45: China 15-Year Perspective for Clinical Laboratory
Services by Test Type - Percentage Breakdown of Value Revenues
for Clinical Chemistry, Human & Tumor Genetics, Medical
Microbiology & Cytology and Other Test Types for the Years
2012, 2021 & 2027

Table 46: China Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Service Provider -
Hospital-based Laboratories, Independent Laboratories and
Physician Office-based Laboratories - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR

Table 47: China Historic Review for Clinical Laboratory
Services by Service Provider - Hospital-based Laboratories,
Independent Laboratories and Physician Office-based
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for Clinical Laboratory
Services by Service Provider - Percentage Breakdown of Value
Revenues for Hospital-based Laboratories, Independent
Laboratories and Physician Office-based Laboratories for the
Years 2012, 2021 & 2027

EUROPE
Clinical Laboratory Services Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2022 (E)
Market Overview
COVID-19 Testing Drives Revenue Growth
Aging Population: Prime Growth Driver
Automated Systems Gain Preeminence
Accreditation and Regulatory Scenario in the EU
Table 49: Europe Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2020 through 2027 and % CAGR

Table 50: Europe Historic Review for Clinical Laboratory
Services by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR

Table 51: Europe 15-Year Perspective for Clinical Laboratory
Services by Geographic Region - Percentage Breakdown of Value
Revenues for France, Germany, Italy, UK, Spain, Russia and Rest
of Europe Markets for Years 2012, 2021 & 2027

Table 52: Europe Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Test Type - Clinical Chemistry,
Human & Tumor Genetics, Medical Microbiology & Cytology and
Other Test Types - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 53: Europe Historic Review for Clinical Laboratory
Services by Test Type - Clinical Chemistry, Human & Tumor
Genetics, Medical Microbiology & Cytology and Other Test Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Clinical Laboratory
Services by Test Type - Percentage Breakdown of Value Revenues
for Clinical Chemistry, Human & Tumor Genetics, Medical
Microbiology & Cytology and Other Test Types for the Years
2012, 2021 & 2027

Table 55: Europe Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Service Provider -
Hospital-based Laboratories, Independent Laboratories and
Physician Office-based Laboratories - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR

Table 56: Europe Historic Review for Clinical Laboratory
Services by Service Provider - Hospital-based Laboratories,
Independent Laboratories and Physician Office-based
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Clinical Laboratory
Services by Service Provider - Percentage Breakdown of Value
Revenues for Hospital-based Laboratories, Independent
Laboratories and Physician Office-based Laboratories for the
Years 2012, 2021 & 2027

FRANCE
Clinical Laboratory Services Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2022 (E)
Table 58: France Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Test Type - Clinical Chemistry,
Human & Tumor Genetics, Medical Microbiology & Cytology and
Other Test Types - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 59: France Historic Review for Clinical Laboratory
Services by Test Type - Clinical Chemistry, Human & Tumor
Genetics, Medical Microbiology & Cytology and Other Test Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2012 through 2019 and % CAGR

Table 60: France 15-Year Perspective for Clinical Laboratory
Services by Test Type - Percentage Breakdown of Value Revenues
for Clinical Chemistry, Human & Tumor Genetics, Medical
Microbiology & Cytology and Other Test Types for the Years
2012, 2021 & 2027

Table 61: France Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Service Provider -
Hospital-based Laboratories, Independent Laboratories and
Physician Office-based Laboratories - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR

Table 62: France Historic Review for Clinical Laboratory
Services by Service Provider - Hospital-based Laboratories,
Independent Laboratories and Physician Office-based
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for Clinical Laboratory
Services by Service Provider - Percentage Breakdown of Value
Revenues for Hospital-based Laboratories, Independent
Laboratories and Physician Office-based Laboratories for the
Years 2012, 2021 & 2027

GERMANY
Clinical Laboratory Services Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2022 (E)
Clinical Laboratory Services in Germany: An Overview
Regulatory/Accreditation Scenario
Table 64: Germany Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Test Type - Clinical Chemistry,
Human & Tumor Genetics, Medical Microbiology & Cytology and
Other Test Types - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 65: Germany Historic Review for Clinical Laboratory
Services by Test Type - Clinical Chemistry, Human & Tumor
Genetics, Medical Microbiology & Cytology and Other Test Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2012 through 2019 and % CAGR

Table 66: Germany 15-Year Perspective for Clinical Laboratory
Services by Test Type - Percentage Breakdown of Value Revenues
for Clinical Chemistry, Human & Tumor Genetics, Medical
Microbiology & Cytology and Other Test Types for the Years
2012, 2021 & 2027

Table 67: Germany Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Service Provider -
Hospital-based Laboratories, Independent Laboratories and
Physician Office-based Laboratories - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR

Table 68: Germany Historic Review for Clinical Laboratory
Services by Service Provider - Hospital-based Laboratories,
Independent Laboratories and Physician Office-based
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for Clinical Laboratory
Services by Service Provider - Percentage Breakdown of Value
Revenues for Hospital-based Laboratories, Independent
Laboratories and Physician Office-based Laboratories for the
Years 2012, 2021 & 2027

ITALY
Table 70: Italy Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Test Type - Clinical Chemistry,
Human & Tumor Genetics, Medical Microbiology & Cytology and
Other Test Types - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 71: Italy Historic Review for Clinical Laboratory
Services by Test Type - Clinical Chemistry, Human & Tumor
Genetics, Medical Microbiology & Cytology and Other Test Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2012 through 2019 and % CAGR

Table 72: Italy 15-Year Perspective for Clinical Laboratory
Services by Test Type - Percentage Breakdown of Value Revenues
for Clinical Chemistry, Human & Tumor Genetics, Medical
Microbiology & Cytology and Other Test Types for the Years
2012, 2021 & 2027

Table 73: Italy Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Service Provider -
Hospital-based Laboratories, Independent Laboratories and
Physician Office-based Laboratories - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR

Table 74: Italy Historic Review for Clinical Laboratory
Services by Service Provider - Hospital-based Laboratories,
Independent Laboratories and Physician Office-based
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for Clinical Laboratory
Services by Service Provider - Percentage Breakdown of Value
Revenues for Hospital-based Laboratories, Independent
Laboratories and Physician Office-based Laboratories for the
Years 2012, 2021 & 2027

UNITED KINGDOM
Clinical Laboratory Services Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2022
(E)
Market Overview
COVID-19 Testing in the UK
Table 76: UK Recent Past, Current & Future Analysis for
Clinical Laboratory Services by Test Type - Clinical Chemistry,
Human & Tumor Genetics, Medical Microbiology & Cytology and
Other Test Types - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 77: UK Historic Review for Clinical Laboratory Services
by Test Type - Clinical Chemistry, Human & Tumor Genetics,

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p04707129/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting